JPWO2023048152A5 - - Google Patents

Info

Publication number
JPWO2023048152A5
JPWO2023048152A5 JP2023549705A JP2023549705A JPWO2023048152A5 JP WO2023048152 A5 JPWO2023048152 A5 JP WO2023048152A5 JP 2023549705 A JP2023549705 A JP 2023549705A JP 2023549705 A JP2023549705 A JP 2023549705A JP WO2023048152 A5 JPWO2023048152 A5 JP WO2023048152A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
formula
hydrogen atom
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023549705A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023048152A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/035044 external-priority patent/WO2023048152A1/ja
Publication of JPWO2023048152A1 publication Critical patent/JPWO2023048152A1/ja
Publication of JPWO2023048152A5 publication Critical patent/JPWO2023048152A5/ja
Pending legal-status Critical Current

Links

JP2023549705A 2021-09-22 2022-09-21 Pending JPWO2023048152A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021153715 2021-09-22
PCT/JP2022/035044 WO2023048152A1 (ja) 2021-09-22 2022-09-21 セロトニン受容体結合活性を有するスピロ複素環誘導体

Publications (2)

Publication Number Publication Date
JPWO2023048152A1 JPWO2023048152A1 (https=) 2023-03-30
JPWO2023048152A5 true JPWO2023048152A5 (https=) 2025-09-30

Family

ID=85719497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023549705A Pending JPWO2023048152A1 (https=) 2021-09-22 2022-09-21

Country Status (4)

Country Link
US (1) US20250026765A1 (https=)
JP (1) JPWO2023048152A1 (https=)
TW (1) TW202328148A (https=)
WO (1) WO2023048152A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057698A2 (en) * 2001-12-28 2003-07-17 Acadia Pharmaceuticals, Inc. Spiroazacyclic compounds as monoamine receptor modulators
DE102005044813A1 (de) * 2005-05-19 2007-10-04 Grünenthal GmbH Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
IL309982A (en) * 2016-11-15 2024-03-01 Univ Temple New modulators of 5-hydroxytryptamine receptor 7 and a method of using them
MX2020007318A (es) * 2017-09-29 2020-08-24 Takeda Pharmaceuticals Co Compuesto heterociclico.
US20240083872A1 (en) * 2020-12-28 2024-03-14 Shionogi & Co., Ltd. Cyclic amine derivatives having serotonin receptor binding activity

Similar Documents

Publication Publication Date Title
JP2019094345A5 (https=)
JP2019104748A5 (https=)
RU2375363C2 (ru) Пирролотриазиновые производные анилина, полезные в качестве ингибиторов киназы
JP2015069090A5 (https=)
JP2015069089A5 (https=)
JPWO2023106310A5 (https=)
JP2015143283A5 (https=)
RU2007139453A (ru) Гетеробициклические ингибиторы вируса гепатита с (hcv)
JP2009526034A5 (https=)
JP2017502006A5 (https=)
JP2016536364A5 (https=)
JP2010504286A5 (https=)
JP2016540742A5 (https=)
JP2023052027A5 (https=)
JP2024511389A5 (https=)
JP2020063289A5 (https=)
JP2022533939A5 (https=)
JP2020521739A5 (https=)
DK1786790T3 (da) Oxazolderivater som histamin H3 receptorstoffer, fremstilling og terapeutiske anvendelser
JPWO2020054788A5 (https=)
RU2314292C2 (ru) Производные азетидина в качестве антагонистов ccr-3 рецептора
RU2010115337A (ru) Трициклические гетероциклические производные
JP2004521913A5 (https=)
JP2007503432A5 (https=)
JP2008525400A5 (https=)